Plain-English translation of NCT04706754 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →PALEOS is a large Canadian study that gathers information from people living with lung cancer to understand how the disease develops, how it's treated, and what outcomes patients experience. Rather than testing a new medication, this study collects real-world data from thousands of patients across multiple hospitals to learn how treatments that were studied in clinical trials actually work when used in everyday medical practice.
Lung cancer is actually many different diseases, and no single hospital has enough patients with each type to study them properly. This study brings together information from hospitals across Canada so researchers can understand treatment patterns and outcomes for all the different types of lung cancer, and learn how treatments translate from the research setting into everyday care.
You likely qualify if…
You likely don't qualify if…
Study staff will identify you through your hospital or clinic records and contact you to explain the study. If you're interested, you'll provide written or verbal consent, and the research team will then access your medical records and information about your lung cancer diagnosis, treatment, and outcomes. There are no additional visits or procedures required — the study uses existing medical information already in your hospital records.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Canada
Collaborators
Pulse Infoframe
Enrollment target
~25,000 participants
Started
April 2020
Primary completion
April 2040
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lynn Vicente
William Osler Health System
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.